Neurotech Pharmaceuticals, Inc.
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2026
Alcon acquires Neurotech Pharmaceuticals
Alcon announced that it had acquired Neurotech Pharmaceuticals for $550 million, with possible additional contingent payments tied to commercial milestones.